company

STABEKK NEVROKIROPRAKTISKE AS

1369 STABEKK

Return on Equity
79,73 %
Current Ratio
0,87
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue4 205 000
Net Income118 000
Total Assets856 000
Total Equity148 000
Income (NOK)2022
Revenue4 205 000
Expenditure4 049 000
Operating Profit156 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax155 000
Tax38 000
Net Income118 000
Balance (NOK)2022
Total Fixed Assets236 000
Total Current Assets620 000
Total Assets856 000
Total Retained Equity118 000
Total Equity148 000
Total Long-Term Debt0
Total Current Debt709 000
Total Equity and Debt856 000
Cash flow (NOK)2022
Sales Income3 481 000
Other Income724 000
Revenue4 205 000
Cost of Goods Sold1 007 000
Salary Costs1 568 000
Depreciation42 000
Impairment0
Expenditure4 049 000
Operating Profit156 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income118 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets43 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures115 000
Total Tangible Assets115 000
Total Fiancial Fixed Assets77 000
Total Fixed Assets236 000
Stock0
Total Investments0
Cash, Bank578 000
Total Current Assets620 000
Total Assets856 000
Total Equity148 000
Short-Term Group Debt408 000
Total Long-Term Debt0
Creditors0
Unpaid Taxes77 000
Dividends0
Other Current Debt224 000
Total Current Debt709 000
Total Equity and Debt856 000
Financial indicators2022
Return on Equity79,73 %
Debt-to-Equity Ratio0
Operating Profit Margin3,71 %
Current Ratio0,87
Quick Ratio0,87
Equity Ratio0,17
Gross Profit Margin76,05 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English